Trial Profile
BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2017
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Acne
- Focus First in man; Therapeutic Use
- Sponsors BioPharmX Corporation
- 26 Jan 2017 According to a BioPharmX Corporation media release, data from this trial will be presented at SPIE Photonics West.
- 22 Aug 2016 Results published in BioPharmX media release.
- 22 Aug 2016 Primary endpoint (Logarithmic Change in Colony Counts of Facial Propionibacterium acnes at four weeks compared to baseline) has been met, as per BioPharmX media release.